Navigation Links
27-Year Pharmaceutical Marketing Leader Ruth Desmond Joins Stream57
Date:1/13/2009

NEW YORK, Jan. 13 /PRNewswire/ -- Stream57, the leading provider of fully customizable webcasting and streaming media communications, is proud to announce that pharmaceutical industry veteran Ruth Desmond has joined the company as Vice President, Healthcare, bringing nearly three decades of experience, knowledge and success to the virtual communications software company. Dr. Desmond assumed the role at the beginning of the new year.

"Stream57 is at the front of the pack and the gap is widening," Desmond said. "I started working with Stream57 several years ago from the other side of the table. I challenged them with new initiatives and aggressive timelines, and found them to be the most customer-centric and flexible vendor that I have worked with in my 27 years in the industry. They always delight clients and customers with their work, and I'm extremely grateful to be a part of such a talented team."

Dr. Desmond began her career in R&D for Eli Lilly and Company and Merck & Co., Inc., but soon took positions in strategic product planning and marketing, most recently serving as Executive Director, Global e-Marketing for Merck. Having worked with Stream57's StreamLine webcasting and media delivery platform for a variety of products and divisions, Dr. Desmond is very familiar with the advantages of using emerging technology in the pharmaceutical and medical marketing business.

"The fact that Stream57 offers project management as well as an amazing development team is key to making projects move efficiently and execute flawlessly," she continued. "If there is a need for physicians or patients, Stream57 can make it happen."

"We are thrilled to add Ruth to our team," Stream57 President Ben Chodor said. "I have the utmost respect for Dr. Desmond - her consistent industry-leading success, impeccable character and unmatched ability to foresee trends and opportunities - we couldn't design
'/>"/>

SOURCE Stream57
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
6. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/7/2009)... Catholics have a responsibility to vigorously opp...us quo." ,, WASHINGTON, Nov. 7 /PRNewswire-...ie Brown released the following statement on the n...er Nancy Pelosi,s Affordable Health Care for Ameri...ng the status quo for abortion is voted upon. ,...
(Date:11/7/2009)... Speaker Nancy Pelosi a...is afternoon following a Democratic Whip meeting w...low are the Speaker,s opening remarks: ,, "Tha...ccasion for us to receive the President of the Uni...ory with our vote and making progress for the Amer...
(Date:11/7/2009)...ublic Relations Society of America (PRSA) will bes...e Lofgren, senior vice president of Brand Strategy...ight at a ceremony at PRSA,s 2009 International Co...he PRSA College of Fellows is one of the professio...n, APR, SAGE, Fellow PRSA, and 2009 chair of the C...
(Date:11/7/2009)...m a growing problem across the U.S. , , SA...students at four-year colleges do it regularly (an... downing five or more alcoholic drinks at a sittin...as a drug," said Jenny Hwang, associate dean of st...ony Brook University on Long Island, N.Y. In fact,...
(Date:11/7/2009)... In the current economic climate, many Americans a...ly spending money on what that they consider to be... David D. Kim believes that it’s very impor...eive treatment to improve their health, and he is ...atients in this tough economy by offering reasonab...
Breaking Medicine News(10 mins):Health News:Statement Regarding Cardinal Rigali's Memo Protecting the 'Status Quo' On Life 2Health News:Pelosi Remarks Following House Democrats' Meeting with President Obama 2Health News:PRSA Inducts Head of Public Relations for Kaiser Permanente Into the College of Fellows for Contributions to the Profession and Lifetime Achievement 2Health News:PRSA Inducts Head of Public Relations for Kaiser Permanente Into the College of Fellows for Contributions to the Profession and Lifetime Achievement 3Health News:Binge Drinking Puts the Brain, and Life Itself, at Risk 2Health News:Binge Drinking Puts the Brain, and Life Itself, at Risk 3Health News:Dallas Bariatric Surgeon Offers Multiple Options for Patients Considering Weight Loss Surgery in a Rough Economy 2Health News:Dallas Bariatric Surgeon Offers Multiple Options for Patients Considering Weight Loss Surgery in a Rough Economy 3
...ped taking drugs in Italian study , , THUR... who stopped taking cholesterol-lowering statins d...ed to those who stayed on the medications, an Ital...lian study comes on the heels of a Spanish study t...
...ecting the disease, doctors have no genetic bluepr...ancer. Tumors generally are ranked by how deeply ...e deeper it burrows into the skin, the more lethal...sion depth and appearance under the microscope can...
... prevent allergic reactions, group suggests , THUR...of people with seasonal allergies may suffer oral ...-reactivity between seasonal airborne pollen prote...me -- include: itchiness, tingling or swelling of ...
... be behind ability to know the tone of a musical n... -- A Web-based do-it-yourself study has found evi...tch, the rare ability to identify the pitch of a m... has absolute pitch?, " said study lead author Jan...
... visits with patients reduced risk by 10% and also...- Case management provided a cost-effective way of...by about 10 percent, according to a study by resea... manage chronic conditions on a long-term basis. C...
...ken to address a 2004 outbreak of the highly infec...has provided the first solid documentation of expe...infection from spreading among patients, staff and...ff, and salaries and lost revenue from closed beds...
Other Medicine News:Health News:Stopping Statins After Stroke Doubles Death Risk 2Health News:Stopping Statins After Stroke Doubles Death Risk 3Health News:Gene signature spells poor outcome 2Health News:Pollen, Fruits, Veggies Help Trigger Oral Allergy Syndrome 2Health News:Is Perfect Pitch All in the Genes? 2Health News:Case Management Cost-Effective Way to Cut Heart Risks 2Health News:Norwalk virus: 'Cruise ship' illness challenging and costly to hospitals, too 2Health News:Norwalk virus: 'Cruise ship' illness challenging and costly to hospitals, too 3Health News:Norwalk virus: 'Cruise ship' illness challenging and costly to hospitals, too 4Health News:Norwalk virus: 'Cruise ship' illness challenging and costly to hospitals, too 5
(Date:11/6/2009)...TON, S.C., Nov. 6 The...in South Carolina and Georgia throughout the week ...p uninsured and financially-struggling patients ac...tion medicines for free or nearly free. With the n..., the Partnership for Prescription Assistance (PPA...
(Date:11/6/2009)...GO, Nov. 6 NuVasive, Inc...ed on developing products for minimally disruptive...y the appointment of Michael J. Lambert as Executi...ective November 9, 2009. The Company also announc.... ,, "Michael will be an excellent complement t...
(Date:11/6/2009)...G, Manitoba, Nov. 6 With his propo...a has set his sights on cutting name-brand prescri...ts who fall into the "Part D" coverage gap, univer...ve about the potential cost-cutting and feel it,s ...of the most powerful lobbyists want a revised prog...
Breaking Medicine Technology:Partnership for Prescription Assistance Prepared to Help Southern Workers Hurt by Recession 2Partnership for Prescription Assistance Prepared to Help Southern Workers Hurt by Recession 3NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 2NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 3NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 4NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 5Obama Healthcare Reforms Fall Short, but Betterthanmedicare.com Closes the 'Donut Hole' 2Obama Healthcare Reforms Fall Short, but Betterthanmedicare.com Closes the 'Donut Hole' 3Hygeia Therapeutics Signs an Exclusive License with Yale University for Potent Safe Topical Anti Androgens 13080 1Hygeia Therapeutics Signs an Exclusive License with Yale University for Potent Safe Topical Anti Androgens 13080 2Hygeia Therapeutics Signs an Exclusive License with Yale University for Potent Safe Topical Anti Androgens 13080 3Don 26apos 3Bt Shoot the Printer Troubleshooting Your Printer Problems 52070 1Don 26apos 3Bt Shoot the Printer Troubleshooting Your Printer Problems 52070 2Don 26apos 3Bt Shoot the Printer Troubleshooting Your Printer Problems 52070 3Prevent Disaster with New Low Cost Temperature Scan Wireless Monitoring System 52067 1Prevent Disaster with New Low Cost Temperature Scan Wireless Monitoring System 52067 2
...se, Enbrel Will Remain the Clinical Gold Standard... Decision Resources, WALTHAM... the world,s leading research and advisory firms f...inds that a drug,s effect on,inhibiting/slowing th...e,signs and symptoms of rheumatoid arthritis durin...
...a,Incorporated (Nasdaq: GNTA ) announced that pre...ium) Injection, the Company,s lead anticancer,comp... American Association,for Cancer Research (AACR). ...il 12-16, 2008. The subject matter of several abst...going randomized Phase 3 trial of,Genasense in pat...
Other Medicine Technology:Current and Emerging Drugs Have No Advantage Over Enbrel in Inhibiting/Slowing the Progression of Rheumatoid Arthritis 2Current and Emerging Drugs Have No Advantage Over Enbrel in Inhibiting/Slowing the Progression of Rheumatoid Arthritis 3Specialized Genasense(R) Clinical Trials Featured at AACR Meeting 2Specialized Genasense(R) Clinical Trials Featured at AACR Meeting 3
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
Medicine Products: